ScripThe Korea Exchange has decided to maintain the stock listing of Kolon TissueGene, Inc. , which has resumed trading on the Kosdaq market after the domestic bioventure fulfilled business improvement co
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Taiho To Pay $275m Up Front For CLN-081
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Juniper Acquires Kolon’s Cell-Mediated
ScripThe late-stage pipeline for the common condition of overactive bladder may be sparse, but the early-to-mid stage pipeline holds potential for new treatment options in the future – and the population i